171 related articles for article (PubMed ID: 21840932)
21. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
22. Lentivirus-mediated PLCγ1 gene short-hairpin RNA suppresses tumor growth and metastasis of human gastric adenocarcinoma.
Zhang B; Wang F; Dai L; Cai H; Zhan Y; Gang S; Hu T; Xia C; Zhang B
Oncotarget; 2016 Feb; 7(7):8043-54. PubMed ID: 26811493
[TBL] [Abstract][Full Text] [Related]
23. Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells
Lu X; Fu H; Chen R; Wang Y; Zhan Y; Song G; Hu T; Xia C; Tian X; Zhang B
Int J Biol Sci; 2020; 16(8):1427-1440. PubMed ID: 32210730
[TBL] [Abstract][Full Text] [Related]
24. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
25. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A.
Su T; Wang YP; Wang XN; Li CY; Zhu PL; Huang YM; Yang ZY; Chen SB; Yu ZL
Life Sci; 2020 Jan; 241():117169. PubMed ID: 31843524
[TBL] [Abstract][Full Text] [Related]
26. Phospholipase Cγ1 is required for pre-TCR signal transduction and pre-T cell development.
Fu G; Yu M; Chen Y; Zheng Y; Zhu W; Newman DK; Wang D; Wen R
Eur J Immunol; 2017 Jan; 47(1):74-83. PubMed ID: 27759161
[TBL] [Abstract][Full Text] [Related]
27. Ursolic Acid Induces Apoptosis in Colorectal Cancer Cells Partially via Upregulation of MicroRNA-4500 and Inhibition of JAK2/STAT3 Phosphorylation.
Kim K; Shin EA; Jung JH; Park JE; Kim DS; Shim BS; Kim SH
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597956
[TBL] [Abstract][Full Text] [Related]
28. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
[TBL] [Abstract][Full Text] [Related]
29. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
30. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.
Zhang X; Guo A; Yu J; Possemato A; Chen Y; Zheng W; Polakiewicz RD; Kinzler KW; Vogelstein B; Velculescu VE; Wang ZJ
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4060-4. PubMed ID: 17360477
[TBL] [Abstract][Full Text] [Related]
31. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
Zhang Q; Liu RX; Chan KW; Hu J; Zhang J; Wei L; Tan H; Yang X; Liu H
J Exp Clin Cancer Res; 2019 Jul; 38(1):320. PubMed ID: 31324203
[TBL] [Abstract][Full Text] [Related]
32. HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.
Syed ZA; Yin W; Hughes K; Gill JN; Shi R; Clifford JL
BMC Cancer; 2011 May; 11():180. PubMed ID: 21595927
[TBL] [Abstract][Full Text] [Related]
33. PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants.
Mittal S; Kamath A; Joseph AM; Rajala MS
Int J Oncol; 2020 Oct; 57(4):989-1000. PubMed ID: 32945365
[TBL] [Abstract][Full Text] [Related]
34. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
[TBL] [Abstract][Full Text] [Related]
35. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
36. Antitumor Activity of Novel Signal Transducer and Activator of Transcription 3 Inhibitors on Retinoblastoma.
Jo DH; Lee S; Bak E; Cho CS; Han YT; Kim K; Suh YG; Kim JH
Mol Pharmacol; 2021 Jul; 100(1):63-72. PubMed ID: 34016717
[TBL] [Abstract][Full Text] [Related]
37. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
38. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.
Yoshida T; Hanada T; Tokuhisa T; Kosai K; Sata M; Kohara M; Yoshimura A
J Exp Med; 2002 Sep; 196(5):641-53. PubMed ID: 12208879
[TBL] [Abstract][Full Text] [Related]
39. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]